Clinical trials in Pruszcz Gdanski

Innovative clinical research focusing on Alzheimer's Disease and Major Depressive Disorder, addressing critical aspects of neurological and psychiatric conditions.

• Alzheimer's-Related Agitation Management
• Depression Treatment Innovation
• Neuropsychiatric Therapeutics

Studies are evaluating novel therapeutic approaches, including the investigation of AVP-786 for agitation in Alzheimer's patients and BH-200 for depression treatment, with a focus on patient safety and symptom improvement.

Comprehensive investigations into mood disorders and behavioral symptoms, with particular attention to developing targeted therapeutic solutions.

• Depression Biomarkers
• Behavioral Symptom Management
• Novel Treatment Approaches

Current research emphasizes personalized medicine approaches, including genetic scoring systems to identify optimal treatment strategies for different patient populations.

Specialized research addressing dementia-related complications and their impact on patient quality of life.

• Behavioral Symptoms in Dementia
• Elderly Patient Care
• Safety and Tolerability Studies

These trials aim to enhance the management of behavioral symptoms in elderly patients, with a particular focus on developing safe and effective treatments for agitation in Alzheimer's disease.